Devyser Diagnostics AB (DVYSR) — Financial Flexibility Index

Latest as of March 2026: 0.11x

Devyser Diagnostics AB (DVYSR) has a Financial Flexibility Index of 0.11x as of March 2026. Free cash flow of Skr12.40 Million (operating CF Skr12.10 Million minus capex Skr300.00K) represents 0% of total liabilities (Skr112.20 Million). Check DVYSR cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Financial Flexibility Index

0.11x
Free Cash Flow / Total Liabilities

Free Cash Flow

Skr12.40 Million
Operating CF − Capex

Total Liabilities

Skr112.20 Million
SEK

Capital Expenditures

Skr300.00K
SEK

Devyser Diagnostics AB Financial Flexibility Index (2018–2025)

Historical Financial Flexibility Index trend for Devyser Diagnostics AB across 8 annual periods. For the full cash flow conversion analysis, see DVYSR cash flow metrics.

Annual Financial Flexibility Index for Devyser Diagnostics AB (2018–2025)

Year-by-year free cash flow to debt coverage for Devyser Diagnostics AB. Explore DVYSR cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Year Flexibility Index Free Cash Flow (SEK) Operating CF Total Liabilities YoY Change
2025 0.08x Skr9.70 Million Skr8.20 Million Skr115.40 Million ▼ -65.1%
2024 0.24x Skr30.10 Million Skr-46.80 Million Skr124.80 Million ▲ +180.0%
2023 -0.30x Skr-37.70 Million Skr-69.70 Million Skr125.00 Million ▼ -41.9%
2022 -0.21x Skr-14.70 Million Skr-40.50 Million Skr69.19 Million ▼ -11.1%
2021 -0.19x Skr-7.68 Million Skr-16.48 Million Skr40.18 Million ▼ -306.2%
2020 0.09x Skr4.04 Million Skr627.00K Skr43.58 Million ▼ -85.8%
2019 0.65x Skr23.94 Million Skr14.63 Million Skr36.69 Million ▲ +7.5%
2018 0.61x Skr11.08 Million Skr6.02 Million Skr18.25 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities